Pictet Asset Management Holding SA Cuts Stock Holdings in Revvity Inc. $RVTY

Pictet Asset Management Holding SA lowered its stake in shares of Revvity Inc. (NYSE:RVTY) by 9.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,363,782 shares of the company’s stock after selling 139,004 shares during the quarter. Pictet Asset Management Holding SA owned 1.20% of Revvity worth $131,958,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also modified their holdings of RVTY. EdgePoint Investment Group Inc. increased its position in shares of Revvity by 26.3% during the third quarter. EdgePoint Investment Group Inc. now owns 8,574,280 shares of the company’s stock worth $751,536,000 after acquiring an additional 1,784,620 shares during the period. Allspring Global Investments Holdings LLC increased its position in shares of Revvity by 127.0% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,751,612 shares of the company’s stock worth $171,921,000 after acquiring an additional 980,142 shares during the period. Dimensional Fund Advisors LP increased its position in shares of Revvity by 39.0% during the third quarter. Dimensional Fund Advisors LP now owns 2,125,957 shares of the company’s stock worth $186,307,000 after acquiring an additional 596,436 shares during the period. Neuberger Berman Group LLC increased its position in shares of Revvity by 4,598.9% during the third quarter. Neuberger Berman Group LLC now owns 460,447 shares of the company’s stock worth $40,358,000 after acquiring an additional 450,648 shares during the period. Finally, Diamond Hill Capital Management Inc. purchased a new stake in shares of Revvity during the third quarter worth $35,206,000. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Revvity Stock Performance

NYSE:RVTY opened at $86.96 on Tuesday. The firm has a market capitalization of $9.72 billion, a PE ratio of 41.81, a price-to-earnings-growth ratio of 1.85 and a beta of 1.13. The business’s fifty day moving average price is $91.16 and its 200 day moving average price is $96.94. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.68 and a quick ratio of 1.40. Revvity Inc. has a 12 month low of $81.36 and a 12 month high of $118.30.

Revvity (NYSE:RVTY) last posted its earnings results on Monday, February 2nd. The company reported $1.70 EPS for the quarter, beating the consensus estimate of $1.55 by $0.15. Revvity had a return on equity of 7.92% and a net margin of 8.45%.The firm had revenue of $772.06 million for the quarter, compared to analyst estimates of $759.81 million. During the same quarter in the prior year, the company posted $1.42 earnings per share. Revvity’s revenue for the quarter was up 5.9% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. On average, sell-side analysts anticipate that Revvity Inc. will post 5.39 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have recently weighed in on RVTY. Barclays reaffirmed an “equal weight” rating and set a $95.00 price objective (down from $118.00) on shares of Revvity in a research report on Tuesday, April 14th. Evercore increased their target price on Revvity from $112.00 to $118.00 and gave the company an “outperform” rating in a report on Tuesday, February 3rd. Wells Fargo & Company increased their target price on Revvity from $107.00 to $110.00 and gave the company an “equal weight” rating in a report on Tuesday, February 3rd. Weiss Ratings lowered Revvity from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, March 18th. Finally, Wall Street Zen lowered Revvity from a “buy” rating to a “hold” rating in a report on Saturday, April 18th. Four investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Revvity presently has an average rating of “Hold” and an average price target of $110.17.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.